DECIPHERA PHARMACEUTICALS IN

CUSIP: 24344T101 Class: Common Stock

Frazier Life Sciences Management, L.P.'s Holding History (CIK: 0001892134)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 1,455,837 Value ($000) $22,900 Avg Close — Range —
Q4 2023
Shares 1,021,800 Value ($000) $16,482 Avg Close — Range —
Q3 2023
Shares 370,000 Value ($000) $4,706 Avg Close — Range —
Q2 2023
Shares 370,000 Value ($000) $5,210 Avg Close — Range —